-5%
Entrovas 50mg Tablet combines Sacubitril and valsartan to combat heart failure.
Entrovas 50mg Tablet is a combination of Sacubitril and Valsartan, belonging to the Angiotensin receptor neprilysin inhibitors group. It is used to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (New York Heart Association Class II-IV) and reduce ejection fraction.
Heart Failure: Heart failure occurs when the heart is weak and unable to pump enough blood to the lungs and the rest of the body. It is characterized by symptoms such as breathlessness, fatigue, tiredness, and ankle swelling.
- Inform your doctor if you have liver, kidney, or heart problems.
- Not recommended for pregnant and breastfeeding women.
- Not suitable for children and adolescents under 18 years.
- Use with caution in elderly patients (65 years and above).
- Inform your doctor about any previous allergies and medication history.
